Onsi Sawiris

Co-Founder, Partner at HOF Capital

📍 New York, New York, United States🔄 Updated September 2026💼 18 investments📅 12 years investing🗓 Last invested Jul 2021
VC🌍 United States
18
Total investments
7
Early stage
4
Mid stage
1
Late stage
12y
Years active

Portfolio

14 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Jul 2021
An end to end platform providing a seamless experience for prospective buyers, sellers & investors in the real estate space. We are a tech-based information & services hub with multiple arms that tackle every step of our clients journey from searching for a home, to buying, selling, consulting and/or investing in properties on a fully immersive digitized platform. Using machine learning and tailored algorithms that foresee & learn customer demands properties are recommended that better suit their needs. The ease of online navigation, the ability to compare different properties and filter according to personal interests allows customers malleability and short search times. Our Nawy Now service allows customers to move in and pay later with reasonable payment plans. This program tackles the adversity of finding ready to move homes by providing a wide array of competitively priced properties with up to 10 year installment plans.
early stageReal Estate
Board Member
Jan 2021
Our vision is to pave the way for your financial independence by redefining the way you manage your money, all while providing a simple and smart digital experience that feels good to have on your side.   Klivvr is a subsidiary of Orascom Financial Holding (OFH), Egypt’s most renowned tech-driven financial services investment platform.
Investor
Jul 2020
Minly is a platform that enables the spread of positivity from (من) a celebrity to (لي) their fan, with the purpose of creating joyous and unforgettable moments through personalized experiences.
early stageEntertainment
Investor
May 2020
insitro is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform the way medicines are created to help patients. At insitro, we are rethinking the entire drug discovery process, from the perspective of machine learning, human genetics, and high-throughput, quantitative biology. Over the past five decades, we have seen the development of new medicines becoming increasingly more difficult and expensive, leaving many patients with significant unmet need. We’re embarking on a new approach to drug development – one that leverages machine learning and unique in vitro strategies for modeling disease state and designing new therapeutic interventions. We aim to eliminate key bottlenecks in traditional drug discovery, so we can help more people sooner and at a much lower cost to the patient and the healthcare industry. We believe that by harnessing the power of technology to interrogate and measure human biology, we can have a major impact on many diseases. We invest heavily in cutting edge bioengineering technologies to enable the construction of large-scale, high-quality data sets that are designed specifically to drive machine learning methods. Our first application is to use human genetics, functional genomics, and machine learning to build a new generation of in vitro human cell-derived disease models whose response to perturbation is designed to be predictive of human clinical outcomes. This cannot be done without great people. We are bringing together an outstanding team of people whose expertise spans multiple disciplines - life sciences, machine learning, human genetics, engineering, and drug discovery - and building a unique culture where people from diverse backgrounds work as a single team towards a common goal. We offer opportunities to collaborative people with expertise in life science and computational science. Join us to help bring better health to more people, faster and cheaper.
Investor
Feb 2020
Swvl is a global provider of transformative tech-enabled mass transit solutions that enhance mass transit safety, reliability, and convenience in some of the world’s most challenging and complex emerging markets. Swvl is uniquely positioned to capitalize on the $1tn global mass transit market opportunity with daily commuting, inter-city travel, TaaS, and SaaS transportation solutions. Swvl currently operates in 115 cities in 18 countries across Latin America, Europe, Africa, and Asia. The differentiated proprietary technology stack features dynamic routing of high capacity vehicles allowing unprecedented vehicle utilization and earnings levels for drivers and massively reduced walk to station distances and prices for riders. With a track record of exponential growth, Swvl achieved annual gross revenue growth of 430% over the past four years. More than 2 million riders to date have booked more than 75 million rides with more than 20 thousand drivers on Swvl’s platform. TaaS offerings have grown gross revenue per client by 4x with > 100% revenue retention over the past two years. Swvl has undergone rapid geographic expansion, including a launch into Europe and Latin America one year ahead of schedule through the recent acquisitions of Shotl and Viapool. Swvl recently entered into a business combination with Queen’s Gambit Growth Capital. Implied, fully diluted equity value is $1.5bn, including an upsized PIPE of $122.5m, of which $65.5mn has been pre-funded to accelerate the company’s growth plans. Swvl is the first $1bn+ unicorn from the region to list on NASDAQ and the first mass transit solutions company on any exchange. The PIPE was led by strategic and financial investors, including Agility, Luxor Capital, Zain, EBRD, and Chimera. Founded on strong ESG principles, Swvl advances social and economic equity while reducing more than 15 million person-hours congestion. Since its inception, the platform has prevented more than 250 million pounds of Co2 emissions.
Investor
Mar 2019
Founded in 2015, aXiomatic Gaming is an esports and gaming investor that provides financial resources and industry expertise to outstanding private companies creating new gaming experiences for players and fans alike. With investments in premier esports organization Team Liquid as well as Epic Games, Niantic and Dapper Labs, aXiomatic has a history of backing and providing strategic value to the trailblazers of the video games and interactive media space.
Board Member
Mar 2019
At the intersection of e-commerce and fintech, Drop is the most effective end-to-end platform that enables brands and merchants to influence and understand Millennial and Gen Z behaviour. By seamlessly connecting their financial institutions, Drop members receive a customized e-commerce experience that allows them to earn rewards for their online and offline purchases and survey completions. Launched in 2017, Drop has over 5 million members in North America and has partnered with over 500 brands, including Amazon, Starbucks and Uber. Our North American Millennial and Gen Z members have spent over $144 billion since the launch of Drop, and provided valuable insights by answering over 100 million survey questions. Drop has raised $80 million from investors such as NEA, ff Venture Capital, Sierra Ventures, CRCM Ventures, Rothenberg Ventures, Hedgewood, White Star Capital, HIGHLINEvc, and RBC Capital.
Co-Founder & Investor
Jan 2019
We are an early-growth stage venture capital fund that backs daring founders building industry-defining companies. We unlock massive growth for our portfolio companies by giving them access to the largest network of distribution channels across the region.
Investor
Aug 2018
Our artificial intelligence and machine learning products deliver automation and human augmentation, allowing individuals and organizations to realize their full potential. Today, the worlds largest organizations rely on ASAPP to provide amazingly efficient and effective customer experiences through their Contact Centers. Our Research & Development team is unparalleled, driving the advancement of AI, machine learning, speech recognition, robotic process automation, natural language processing and more. If you are interested in working with us, please send an email to info@asapp.com. If youre interested in learning about our job opportunities, please reach out at careers@asapp.com.
Board Member
May 2018
RiverBank’s mission is to be the digital bank that makes financing to SMEs and Real Estate professionals easy. From our offices in Amsterdam and Paris and our head-office in Luxemburg we act as a niche lending specialist. Our core focus is to grant loans to Small and Medium Enterprises and Real Estate Investors in Europe using a fast, flexible and reliable IT platform. RiverBank operates under a full and universal European Banking Licence delivering a one-stop shop approach in the entire EU. As a young company, the talent and passion of our people is critical to our success. Together, we share a common set of values rooted in integrity, excellence and strong team work. RiverBank will offer an entrepreneurial environment within the regulatory banking framework - a place for people to learn, to achieve and grow. Our culture will promote diversity and individual perspectives in an international environment, represented by more than 15 nationalities. At RiverBank, we cherish our employees and foster a culture of learning and improvement. From your first day - where you will join a dedicated program to ensure your integration is successful - until many years later, you will be given the required resources to develop personally so that your career at RiverBank gives you a meaningful and lifelong learning experience. #Fintech #CorporateLending #banking #SME #Loans #Advisors #Benelux #Germany #Netherlands #France #Luxembourg #Bank
early stageBanking
Co-Founder & Investor
Jan 2018
WAYA Media is an independent media and entertainment company that reports on the people and stories shaping the future of the Middle East.
Investor
Jun 2017
The self-driving car is here.
Board Member
Jan 2016
Optii is a hotel operations technology that optimizes labor, streamlines operations, and empowers teams across housekeeping, service delivery, internal communication, and preventative maintenance. Optii is an MCR portfolio company and is used by hotels and resorts around the world including La Cantera Resort & Spa (Benchmark), The Don Cesar (Host), Okada Manilla Resort & Casino, Le Meridien, Doma Hotels, IHG and more.
Board Member
Oct 2014
Mobile music for everyone! Mach Music has created a portfolio of Value Added Services that brings the latest apps, content and engagement to consumers directly or through its partners: mobile operators and OEMs.
Experience · 21 entries
All (21)
Investments (16)
Founder (4)
Board (8)
2021
Board Member
Jul 2021
An end to end platform providing a seamless experience for prospective buyers, sellers & investors in the real estate space. We are a tech-based information & services hub with multiple arms that tackle every step of our clients journey from searching for a home, to buying, selling, consulting and/or investing in properties on a fully immersive digitized platform. Using machine learning and tailored algorithms that foresee & learn customer demands properties are recommended that better suit their needs. The ease of online navigation, the ability to compare different properties and filter according to personal interests allows customers malleability and short search times. Our Nawy Now service allows customers to move in and pay later with reasonable payment plans. This program tackles the adversity of finding ready to move homes by providing a wide array of competitively priced properties with up to 10 year installment plans.
early stageReal Estate
Board Member
Jan 2021
Our vision is to pave the way for your financial independence by redefining the way you manage your money, all while providing a simple and smart digital experience that feels good to have on your side.   Klivvr is a subsidiary of Orascom Financial Holding (OFH), Egypt’s most renowned tech-driven financial services investment platform.
2020
Investor
Dec 2020
SpaceX designs, manufactures and launches the world’s most advanced rockets and spacecraft. The company was founded in 2002 by Elon Musk to revolutionize space transportation, with the ultimate goal of making life multiplanetary. SpaceX has gained worldwide attention for a series of historic milestones. It is the only private company ever to return a spacecraft from low-Earth orbit, which it first accomplished in December 2010. The company made history again in May 2012 when its Dragon spacecraft attached to the International Space Station, exchanged cargo payloads, and returned safely to Earth — a technically challenging feat previously accomplished only by governments. Since then Dragon has delivered cargo to and from the space station multiple times, providing regular cargo resupply missions for NASA. For more information, visit www.spacex.com.
Investor
Jul 2020
Minly is a platform that enables the spread of positivity from (من) a celebrity to (لي) their fan, with the purpose of creating joyous and unforgettable moments through personalized experiences.
early stageEntertainment
Investor
May 2020
insitro is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform the way medicines are created to help patients. At insitro, we are rethinking the entire drug discovery process, from the perspective of machine learning, human genetics, and high-throughput, quantitative biology. Over the past five decades, we have seen the development of new medicines becoming increasingly more difficult and expensive, leaving many patients with significant unmet need. We’re embarking on a new approach to drug development – one that leverages machine learning and unique in vitro strategies for modeling disease state and designing new therapeutic interventions. We aim to eliminate key bottlenecks in traditional drug discovery, so we can help more people sooner and at a much lower cost to the patient and the healthcare industry. We believe that by harnessing the power of technology to interrogate and measure human biology, we can have a major impact on many diseases. We invest heavily in cutting edge bioengineering technologies to enable the construction of large-scale, high-quality data sets that are designed specifically to drive machine learning methods. Our first application is to use human genetics, functional genomics, and machine learning to build a new generation of in vitro human cell-derived disease models whose response to perturbation is designed to be predictive of human clinical outcomes. This cannot be done without great people. We are bringing together an outstanding team of people whose expertise spans multiple disciplines - life sciences, machine learning, human genetics, engineering, and drug discovery - and building a unique culture where people from diverse backgrounds work as a single team towards a common goal. We offer opportunities to collaborative people with expertise in life science and computational science. Join us to help bring better health to more people, faster and cheaper.
Show all 21 entries ↓
Investment activity
2014–2021 · 18 investments
20141201612017320183201942020420212
Recent (last 2 years)Earlier